Characteristics of bone marrow transplantations
| Characteristic . | Value . |
|---|---|
| Median cell dose per kg | 2.43 × 108 |
| Median (range) donor age, y | 36 (18-60) |
| Median (range) recipient age, y | 29 (0-66) |
| Radiation therapy, no. (%) | |
| None | 1072 (20) |
| Total body | 4129 (79) |
| Thoracoabdominal | 4 (0) |
| Total lymphoid/nodal | 26 (0) |
| Other | 15 (0) |
| Graft-versus-host disease prophylaxis, no. (%) | |
| T-cell depletion | 1293 (25) |
| Methotrexate | 3779 (72) |
| Cyclosporine A | 4298 (82) |
| Growth-factor administration, no. (%) | 3487 (66) |
| Time marrow collected before BMT, no. (%)3-150 | |
| < 12 hours | 2054 (41) |
| 12-24 hours | 2064 (41) |
| > 24 hours | 860 (17) |
| Characteristic . | Value . |
|---|---|
| Median cell dose per kg | 2.43 × 108 |
| Median (range) donor age, y | 36 (18-60) |
| Median (range) recipient age, y | 29 (0-66) |
| Radiation therapy, no. (%) | |
| None | 1072 (20) |
| Total body | 4129 (79) |
| Thoracoabdominal | 4 (0) |
| Total lymphoid/nodal | 26 (0) |
| Other | 15 (0) |
| Graft-versus-host disease prophylaxis, no. (%) | |
| T-cell depletion | 1293 (25) |
| Methotrexate | 3779 (72) |
| Cyclosporine A | 4298 (82) |
| Growth-factor administration, no. (%) | 3487 (66) |
| Time marrow collected before BMT, no. (%)3-150 | |
| < 12 hours | 2054 (41) |
| 12-24 hours | 2064 (41) |
| > 24 hours | 860 (17) |
BMT indicates bone marrow transplantation.
Collection time was unknown for 268 patients.